Article: Dyslipidemia and Superoxide Dismutase Activity in Children with Down Syndrome
| dc.contributor.author | Goyal, P | |
| dc.contributor.author | Singh, R | |
| dc.contributor.author | Yadav, A | |
| dc.contributor.author | Dutta, AK | |
| dc.contributor.author | Bhattacharjee, J | |
| dc.date.accessioned | 2026-06-04T08:31:28Z | |
| dc.date.available | 2026-06-04T08:31:28Z | |
| dc.date.issued | 2010 | |
| dc.description | P Goyal Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi R Singh Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi A Yadav Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi AK Dutta Department of Paediatrics, Kalawati Saran Children’s Hospital, Lady Hardinge Medical College, New Delhi J Bhattacharjee Department of Paediatrics, Kalawati Saran Children’s Hospital, Lady Hardinge Medical College, New Delhi | |
| dc.description.abstract | Abstract: Introduction: Down Syndrome (trisomy 21) provides an interesting natural model to study atherosclerosis, since these individuals appear to be protected from plaque formation. Methodology: We assessed the lipid levels, and superoxide dismutase (SOD) activity in 32 clinically diagnosed children of Down syndrome and 34 children matched for age and sex as controls. Results: SOD activity was found to be significantly higher (p=0.004) in children with Down Syndrome (mean=313.7 IU/ml) than in controls (mean140.2 IU/ ml). Significantly higher levels of serum triglyceride (154.7 mg/dl) and VLDL (33.9 mg/dl) were observed in Down Syndrome as compared to healthy controls (119.6 mg/dl and 23.9 mg/dl respectively; p<0.05 for each). However, the two groups did not show any significant difference in levels of serum HDL-C, LDL-C. Conclusion: The raised antioxidant activity of SOD, because of over expression of genes situated non chromosome 21, probably offers some protection against the development of atherosclerosis despite the occurrence of dyslipidemia. | |
| dc.identifier | https://doi.org/10.3126/jnps.v30i3.3919 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/6366 | |
| dc.language.iso | en_US | |
| dc.publisher | Nepal Paediatric Society (JNPS) | |
| dc.subject | Chromosome 21 | |
| dc.subject | Down Syndrome | |
| dc.subject | Trisomy 21 | |
| dc.subject | Superoxide dismutase | |
| dc.title | Dyslipidemia and Superoxide Dismutase Activity in Children with Down Syndrome | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 163 | |
| oaire.citation.startPage | 160 |